Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Debt (2016 - 2026)

Mimedx's Total Debt history spans 12 years, with the latest figure at $17.6 million for Q1 2026.

  • On a quarterly basis, Total Debt fell 5.7% to $17.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.6 million, a 5.7% decrease, with the full-year FY2025 number at $18.0 million, down 4.58% from a year prior.
  • Total Debt hit $17.6 million in Q1 2026 for Mimedx, down from $18.0 million in the prior quarter.
  • Over the last five years, Total Debt for MDXG hit a ceiling of $49.1 million in Q4 2023 and a floor of $17.6 million in Q1 2026.
  • Historically, Total Debt has averaged $32.8 million across 5 years, with a median of $20.4 million in 2024.
  • Biggest five-year swings in Total Debt: increased 1.04% in 2023 and later plummeted 61.65% in 2024.
  • Tracing MDXG's Total Debt over 5 years: stood at $48.6 million in 2022, then grew by 1.04% to $49.1 million in 2023, then tumbled by 61.65% to $18.8 million in 2024, then fell by 4.58% to $18.0 million in 2025, then dropped by 2.08% to $17.6 million in 2026.
  • Business Quant data shows Total Debt for MDXG at $17.6 million in Q1 2026, $18.0 million in Q4 2025, and $18.2 million in Q3 2025.